In large human transcriptomic and sequencing datasets, a role for CD4<sup>+</sup> T cells in enhancing immune checkpoint blocker-mediated responses in persons with melanoma and mismatch-repair-deficient colon cancers that have downregulated MHC class I was suggested. The gene discussed is CD4; the disease is melanoma.